According to McKinsey and Company, the battery storage market is growing rapidly, especially with the transition to clean, renewable energy.

Lithium-ion batteries still grab most of the headlines. But analysts now call safe and long-lasting batteries made with vanadium "the future of battery tech."

See why investors are taking a hard look

VIGL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 33.45%

Insider Buying (Last 12 Months): $15,000.00

Insider Selling (Last 12 Months): $0.00

Vigil Neuroscience Insider Trading History Chart

Vigil Neuroscience Share Price & Price History

^$3.53

▲ +0.08 (2.32%)

As of 12/8/2023 09:58 PM ET

Days: 30 | 90 | 365

How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology

From Autonomix | Ad

Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

Invest in Autonomix today.

Vigil Neuroscience Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/20/2023	Ivana Magovcevic-Liebisch	CEO	Buy	4,000	$3.75	$15,000.00	207,687
11/18/2022	Spyros Papapetropoulos	Insider	Sell	300	$14.00	$4,200.00	4,000
5/16/2022	Clay Thorp	Director	Buy	21,802	$2.76	$60,173.52	1,541,137
5/5/2022	Evan Thackaberry	SVP	Buy	1,500	$4.00	$6,000.00	1,500
5/3/2022	Christopher Verni	General Counsel	Buy	4,000	$3.77	$15,080.00	4,000
5/3/2022	Ivana Magovcevic-Liebisch	CEO	Buy	1,000	$3.94	$3,940.00	203,687
3/28/2022	Clay Thorp	Director	Buy	3,000	$7.20	$21,600.00

Lithium Discovery So BIG You Can't Miss it, Even From Space

From Financial Alphas | Ad

With the green energy transition well underway, lithium demand is rapidly outpacing projected supply. While companies frantically search for new sources of this critical metal, one small company is sitting on a massive claim in North America - So big in fact that it can clearly be seen from space!

Free Investor Report Reveals Ambitious Plan To Mee

SEC Filings (Institutional Ownership Changes) for Vigil Neuroscience (NASDAQ:VIGL)

71.80% of Vigil Neuroscience stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Vigil Neuroscience Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/6/2023	Citigroup Inc.	64,303	$0.35M	0.0%	-6.9%	0.179%
11/15/2023	Laurion Capital Management LP	10,839	$58K	0.0%	-89.1%	0.030%
11/14/2023	Deerfield Management Company L.P. Series C	1,827,400	$9.85M	0.2%	-10.9%	5.093%
11/14/2023	PEAK6 Investments LLC	23,796	$0.13M	0.0%	+66.0%	0.066%
11/9/2023	Citigroup Inc.	64,303	$0.35M	0.0%	-6.9%	0.179%
8/21/2023	California State Teachers Retirement System	5,345	$50K	0.0%	N/A	0.015%
8/15/2023	Wells Fargo & Company MN	6,096	$57K	0.0%	+6,988.4%	0.017%
8/15/2023	Goldman Sachs Group Inc.	13,008	$0.12M	0.0%	-47.6%	0.036%
8/15/2023	Royal Bank of Canada	3,499	$33K	0.0%	N/A	0.010%
8/15/2023	Citadel Advisors LLC	2,180,324	$20.50M	0.0%	+0.9%	6.078%
8/14/2023	State Street Corp	259,699	$2.44M	0.0%	+626.7%	0.724%
8/14/2023	Deep Track Capital LP	1,773,409	$16.67M	0.8%	-12.4%	4.944%
8/14/2023	Nuveen Asset Management LLC	24,715	$0.23M	0.0%	N/A	0.069%
8/11/2023	PEAK6 Investments LLC	14,337	$0.14M	0.0%	N/A	0.040%
8/11/2023	BlackRock Inc.	821,452	$7.72M	0.0%	+704.7%	2.290%
8/11/2023	Geode Capital Management LLC	284,843	$2.68M	0.0%	+153.4%	0.794%
8/11/2023	Artal Group S.A.	1,911,191	$17.97M	0.6%	-14.8%	5.328%
8/11/2023	JPMorgan Chase & Co.	12,805	$0.12M	0.0%	N/A	0.036%
8/11/2023	Northern Trust Corp	124,362	$1.17M	0.0%	+459.3%	0.347%
8/10/2023	MetLife Investment Management LLC	9,105	$86K	0.0%	N/A	0.026%
8/10/2023	Charles Schwab Investment Management Inc.	41,968	$0.39M	0.0%	N/A	0.118%
8/10/2023	Citigroup Inc.	69,077	$0.65M	0.0%	-24.4%	0.194%
8/4/2023	American International Group Inc.	7,734	$73K	0.0%	N/A	0.022%
8/3/2023	Bank of New York Mellon Corp	48,488	$0.46M	0.0%	N/A	0.136%
8/2/2023	Bank of Montreal Can	73,243	$0.73M	0.0%	N/A	0.205%
5/16/2023	Susquehanna International Group LLP	58,718	$0.58M	0.0%	+114.5%	0.165%
5/16/2023	Jane Street Group LLC	27,184	$0.27M	0.0%	N/A	0.076%
5/16/2023	Geode Capital Management LLC	112,392	$1.10M	0.0%	+8.3%	0.315%
5/12/2023	Bank of America Corp DE	19,322	$0.19M	0.0%	+95.3%	0.054%
5/11/2023	Citigroup Inc.	91,398	$0.90M	0.0%	-2.7%	0.256%
5/4/2023	Barclays PLC	104,248	$1.02M	0.0%	-1.6%	0.292%
2/15/2023	Trustees of Columbia University in the City of New York	192,973	$2.41M	5.0%	N/A	0.542%
2/15/2023	Morgan Stanley	9,092	$0.11M	0.0%	+6,893.8%	0.026%
2/14/2023	Susquehanna International Group LLP	27,375	$0.34M	0.0%	N/A	0.077%
2/14/2023	683 Capital Management LLC	15,092	$0.19M	0.0%	N/A	0.042%
2/13/2023	Barclays PLC	105,893	$1.32M	0.0%	+3.7%	0.298%
2/13/2023	Geode Capital Management LLC	103,767	$1.30M	0.0%	+44.5%	0.292%
2/13/2023	Artal Group S.A.	2,243,352	$28.04M	1.6%	-1.8%	6.305%
2/10/2023	Bank of America Corp DE	9,896	$0.12M	0.0%	N/A	0.028%
2/9/2023	Citigroup Inc.	93,927	$1.17M	0.0%	+38.8%	0.264%
2/1/2023	Bank of Montreal Can	58,100	$0.73M	0.0%	N/A	0.163%
11/15/2022	State Street Corp	21,374	$0.20M	0.0%	+16.3%	0.060%
11/15/2022	Vanguard Group Inc.	365,426	$3.33M	0.0%	+3.2%	1.027%
11/15/2022	BVF Inc. IL	1,813,633	$16.50M	0.7%	N/A	5.097%
11/15/2022	BlackRock Inc.	101,725	$0.93M	0.0%	-2.4%	0.286%
11/15/2022	Citadel Advisors LLC	2,166,467	$19.72M	0.0%	+0.1%	6.089%
11/14/2022	Ergoteles LLC	28,533	$0.26M	0.0%	N/A	0.101%
11/14/2022	Altium Capital Management LP	15,788	$0.14M	0.1%	N/A	0.056%
8/15/2022	State Street Corp	18,374	$47K	0.0%	-66.3%	0.065%
8/15/2022	Citadel Advisors LLC	2,165,036	$5.47M	0.0%	+0.1%	7.659%
8/15/2022	Laurion Capital Management LP	130,200	$0.34M	0.0%	N/A	0.461%
8/13/2022	Renaissance Technologies LLC	37,488	$97K	0.0%	+87.1%	0.133%
8/12/2022	Northern Trust Corp	12,082	$31K	0.0%	-78.7%	0.043%
5/17/2022	Point72 Hong Kong Ltd	12,667	$89K	0.0%	N/A	0.045%
5/17/2022	Rock Springs Capital Management LP	471,958	$3.32M	0.1%	N/A	1.669%
5/16/2022	Goldman Sachs Group Inc.	73,839	$0.52M	0.0%	N/A	0.261%
5/16/2022	Deep Track Capital LP	389,141	$2.74M	0.2%	N/A	1.377%
5/16/2022	State Street Corp	54,479	$0.38M	0.0%	N/A	0.193%
5/13/2022	Renaissance Technologies LLC	20,041	$0.14M	0.0%	N/A	0.071%
5/13/2022	Northern Trust Corp	56,683	$0.40M	0.0%	N/A	0.201%
5/13/2022	Charles Schwab Investment Management Inc.	19,198	$0.14M	0.0%	N/A	0.068%
5/13/2022	Vanguard Group Inc.	385,198	$2.71M	0.0%	N/A	1.363%
5/12/2022	BlackRock Inc.	303,689	$2.14M	0.0%	N/A	1.074%
5/12/2022	Artal Group S.A.	1,121,191	$7.88M	0.3%	N/A	3.966%
5/12/2022	Citigroup Inc.	64,094	$0.45M	0.0%	N/A	0.227%
5/11/2022	Bank of New York Mellon Corp	13,341	$94K	0.0%	N/A	0.047%
5/5/2022	New York State Common Retirement Fund	8,500	$60K	0.0%	N/A	0.030%

Data available starting January 2016

Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Its lead candidate is VGL101, a human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 and is in a Phase 2 proof-of-concept trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. The company is also conducting IND-enabling studies with a novel small molecule TREM2 agonist program to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer's disease in genetically defined subpopulations. Vigil Neuroscience, Inc. was incorporated in 2020 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $3.53

$3.37

$3.60

50 Day Range

MA: $5.53

$2.97

$8.60

52 Week Range

Now: $3.53

$2.85

$13.10

Volume

76,000 shs

Average Volume

58,356 shs

Market Capitalization

$126.65 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.73

Who are the company insiders with the largest holdings of Vigil Neuroscience?: Vigil Neuroscience's top insider shareholders include:
Clay Thorp (Director)
Ivana Magovcevic-Liebisch (CEO)
Christopher Verni (General Counsel)
Spyros Papapetropoulos (Insider)
Evan Thackaberry (SVP)
Learn More about top insider investors at Vigil Neuroscience.
Who are the major institutional investors of Vigil Neuroscience?: Vigil Neuroscience's top institutional investors include:
Deerfield Management Company L.P. Series C — 5.09%
Citigroup Inc. — 0.18%
Citigroup Inc. — 0.18%
PEAK6 Investments LLC — 0.07%
Laurion Capital Management LP — 0.03%
Learn More about top institutional investors of Vigil Neuroscience stock.
Which major investors are selling Vigil Neuroscience stock?: In the previous quarter, VIGL stock was sold by these institutional investors:
Deerfield Management Company L.P. Series C
Laurion Capital Management LP
Citigroup Inc.
Citigroup Inc.
Which major investors are buying Vigil Neuroscience stock?: Within the previous quarter, VIGL stock was bought by institutional investors including:
PEAK6 Investments LLC
Within the last year, these company insiders have bought Vigil Neuroscience stock:
Clay Thorp (Director)
Ivana Magovcevic-Liebisch (CEO)
Christopher Verni (General Counsel)
Spyros Papapetropoulos (Insider)
Learn More investors buying Vigil Neuroscience stock.